AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7960018 — intervention group
Group type: COMPARATOR
Intervention: 235T allele frequency in normotensive group (82%)
Number of subjects: 187
Study 7960018 — intervention group
Group type: EXPERIMENTAL
Intervention: 174M allele frequency in hypertensive group
Number of subjects: 187
Study 7960018 — intervention group
Group type: COMPARATOR
Intervention: 174M allele frequency in normotensive group
Number of subjects: 187
Study 7960018 — intervention group
Group type: EXPERIMENTAL
Intervention: 235T allele frequency in Nigerian sample (93%)
Number of subjects: 187
Study 3331045 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin (0.5 g six hourly)
Number of subjects: 45
Study 3331045 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (ampicillin 0.5 g six hourly, metronidazole 0.5 g eight hourly, gentamicin 80 mg eight hourly)
Number of subjects: 45
Study 29126824 — intervention group
Group type: EXPERIMENTAL
Intervention: Seventeen Days (treatment intervention; sex education)
Number of subjects: 100
Study 29126824 — intervention group
Group type: COMPARATOR
Intervention: Driving Skills for Life (control intervention; driving education)
Number of subjects: 100
Study 27866133 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete revascularisation during a staged procedure before discharge
Number of subjects: 627
Study 27866133 — intervention group
Group type: COMPARATOR
Intervention: IRA-PCI only
Number of subjects: 627
Study 27866133 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete revascularisation
Number of subjects: 627
Study 26690812 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotics for the first 6 weeks of therapy
Number of subjects: 1050
Study 26690812 — intervention group
Group type: COMPARATOR
Intervention: Intravenous antibiotics for the first 6 weeks of therapy
Number of subjects: 1050
Study 23201175 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide (70-100mg per day)
Number of subjects: 258
Study 22192273 — intervention group
Group type: EXPERIMENTAL
Intervention: MINT-TLC (therapeutic lifestyle intervention)
Number of subjects: 200
Study 22192273 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 200
Study 18326990 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring by an advanced practice nurse
Number of subjects: 102
Study 18326990 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 102
Study 17002724 — intervention group
Group type: EXPERIMENTAL
Intervention: AS + AQ
Number of subjects: 180
Study 17002724 — intervention group
Group type: COMPARATOR
Intervention: AS + SP
Number of subjects: 180
Study 14570676 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.27% wt/vol
Number of subjects: 60
Study 14570676 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.31% wt/vol
Number of subjects: 60
Study 14570676 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine/bupivacaine potency ratio
Number of subjects: 60
Study 11053761 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (8 weeks)
Number of subjects: 208
Study 8880820 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam loading dose 0.08 mg.kg‐1
Number of subjects: 23
Study 8880820 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam loading dose 0.04 mg.kg‐1
Number of subjects: 23
Study 8880820 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.00 mg.kg‐1)
Number of subjects: 23
Study 8299441 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (250 mg 3 times/day)
Number of subjects: 13
Study 8299441 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg 3 times/day)
Number of subjects: 13
Study 8299441 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 13
Study 8299441 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin and Metoclopramide
Number of subjects: 13
Study 3522372 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly endoscopic sclerotherapy
Number of subjects: 96
Study 3522372 — intervention group
Group type: COMPARATOR
Intervention: Three weeks endoscopic sclerotherapy
Number of subjects: 96
Study 29526840 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity training (HIT) - 100% VO2Max cardiovascular and 80% 1RM resistance training, 12 sessions, 1.5 hours/session, 2 x/week for 6 weeks
Number of subjects: 20
Study 29526840 — intervention group
Group type: COMPARATOR
Intervention: Average intensity/load conventional physical therapy (CON) - 60% VO2max
Number of subjects: 20
Study 27288375 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal education in small classes (3 sessions of 2.5 hours each)
Number of subjects: 1766
Study 27288375 — intervention group
Group type: COMPARATOR
Intervention: Standard auditorium-based lectures (2 sessions of 2 hours each)
Number of subjects: 1766
Study 25011274 — intervention group
Group type: EXPERIMENTAL
Intervention: Safflower treatment group
Number of subjects: 93
Study 25011274 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI group
Number of subjects: 93
Study 22591582 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based obesity prevention intervention
Number of subjects: 225
Study 22591582 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 225
Study 20541263 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverted internal limiting membrane (ILM) flap technique
Number of subjects: 86
Study 20541263 — intervention group
Group type: COMPARATOR
Intervention: Standard 3-port pars plana vitrectomy with air
Number of subjects: 86
Study 18512752 — intervention group
Group type: EXPERIMENTAL
Intervention: Push and Release Test (P&R) in OFF medication state
Number of subjects: 82
Study 18512752 — intervention group
Group type: COMPARATOR
Intervention: Pull Test in OFF medication state
Number of subjects: 82
Study 18512752 — intervention group
Group type: EXPERIMENTAL
Intervention: Push and Release Test (P&R) in ON medication state
Number of subjects: 82
Study 18512752 — intervention group
Group type: COMPARATOR
Intervention: Pull Test in ON medication state
Number of subjects: 82
Study 15687314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen plus continuous positive airway pressure
Number of subjects: 209
Study 15687314 — intervention group
Group type: COMPARATOR
Intervention: Oxygen
Number of subjects: 209
Study 12844138 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (250 mg twice daily)
Number of subjects: 12
Study 12844138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10804140 — intervention group
Group type: EXPERIMENTAL
Intervention: Human caliciviruses (NLVs and SLVs)
Number of subjects: 832
Study 10804140 — intervention group
Group type: EXPERIMENTAL
Intervention: Human caliciviruses (SLVs)
Number of subjects: 832
Study 10804140 — intervention group
Group type: EXPERIMENTAL
Intervention: Astroviruses
Number of subjects: 832
Study 10804140 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric adenoviruses
Number of subjects: 832
Study 10804140 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotaviruses
Number of subjects: 832
Study 10804140 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis with PCR and RT-PCR methods
Number of subjects: 832
Study 8872646 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training
Number of subjects: 26
Study 8872646 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 26
Study 8872646 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 26
Study 1310834 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (8 mg)
Number of subjects: 19
Study 1310834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (4 mg)
Number of subjects: 19
Study 1310834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 1310834 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 19
Study 2485268 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous angiotensin II infusions (2-16 ng min-1 kg-1)
Number of subjects: 10
Study 30659397 — intervention group
Group type: COMPARATOR
Intervention: Valenti technique
Number of subjects: 568
Study 30659397 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein technique
Number of subjects: 568
Study 29455058 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with physical activity (RPA group)
Number of subjects: 41
Study 29455058 — intervention group
Group type: COMPARATOR
Intervention: Resistance training (RT group)
Number of subjects: 41
Study 27365472 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-matched positioning guides (PMPGs)
Number of subjects: 180
Study 25255799 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient oriented decision aid for prioritising treatment goals in diabetes
Number of subjects: 344
Study 25255799 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed version of the decision aid
Number of subjects: 344
Study 25255799 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study 23364778 — intervention group
Group type: EXPERIMENTAL
Intervention: Infraclavicular block (Group I)
Number of subjects: 110
Study 23364778 — intervention group
Group type: COMPARATOR
Intervention: Supraclavicular block (Group S)
Number of subjects: 110
Study 20425645 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week CBT skill training program delivered on a DVD
Number of subjects: 70
Study 20425645 — intervention group
Group type: COMPARATOR
Intervention: General educational DVD program on dementia
Number of subjects: 70
Study 18721510 — intervention group
Group type: COMPARATOR
Intervention: Edifoligide (placebo-controlled)
Number of subjects: 3014
Study 16284203 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT plus medical therapy
Number of subjects: 813
Study 16284203 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 813
Study 11910263 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (60 mg daily)
Number of subjects: 26
Study 11910263 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (75 mg twice daily)
Number of subjects: 26
Study 11910263 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with either fluoxetine or imipramine
Number of subjects: 26
Study 11910263 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety assessments
Number of subjects: 26
Study 10622015 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block
Number of subjects: 30
Study 10622015 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injections
Number of subjects: 30
Study 7852498 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovine corticotropin-releasing hormone (CRH) 100 micrograms iv bolus
Number of subjects: 10
Study 7852498 — intervention group
Group type: EXPERIMENTAL
Intervention: Human corticotropin-releasing hormone (CRH) 100 micrograms iv bolus
Number of subjects: 10
Study 7852498 — intervention group
Group type: EXPERIMENTAL
Intervention: Cushing's disease (both CRH types)
Number of subjects: 10
Study 7852498 — intervention group
Group type: COMPARATOR
Intervention: Ovine CRH
Number of subjects: 10
Study 7852498 — intervention group
Group type: COMPARATOR
Intervention: Human CRH
Number of subjects: 10
Study 7852498 — intervention group
Group type: COMPARATOR
Intervention: Adrenal tumors (both CRH types)
Number of subjects: 10
Study 1952268 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (600 mg in 250 mL saline infused over six hours)
Number of subjects: 5
Study 1952268 — intervention group
Group type: EXPERIMENTAL
Intervention: PET scan
Number of subjects: 5
Study 1952268 — intervention group
Group type: COMPARATOR
Intervention: Plethysmography
Number of subjects: 5
Study 1952268 — intervention group
Group type: COMPARATOR
Intervention: Blood samples
Number of subjects: 5
Study 6993111 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple dye
Number of subjects: 0
Study 6993111 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine
Number of subjects: 0
Study 6993111 — intervention group
Group type: COMPARATOR
Intervention: Castile soap
Number of subjects: 0
Study 30772908 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral perfusion-targeted resuscitation (normalizing capillary refill time)
Number of subjects: 424
Study 30772908 — intervention group
Group type: COMPARATOR
Intervention: Lactate level-targeted resuscitation (normalizing or decreasing lactate levels)
Number of subjects: 424
Study 30772908 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral perfusion-targeted resuscitation
Number of subjects: 424
Study 30772908 — intervention group
Group type: COMPARATOR
Intervention: Lactate level-targeted resuscitation
Number of subjects: 424
Study 29019559 — intervention group
Group type: EXPERIMENTAL
Intervention: Herniotomy without incising external oblique aponeurosis
Number of subjects: 800
Study 29019559 — intervention group
Group type: COMPARATOR
Intervention: Herniotomy with incising external oblique aponeurosis
Number of subjects: 800
Study 25335948 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine challenge (smoking a nicotinized cigarette)
Number of subjects: 142
Study 25335948 — intervention group
Group type: COMPARATOR
Intervention: Nicotine abstinence (continuing to abstain from smoking)
Number of subjects: 142
Study 25335948 — intervention group
Group type: COMPARATOR
Intervention: Denicotinized cigarette
Number of subjects: 142
Study 24820288 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin cream
Number of subjects: 24
Study 24820288 — intervention group
Group type: COMPARATOR
Intervention: Placebo (inert lotion)
Number of subjects: 24
Study 24820288 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 22930487 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 10-0-5-0 mg (treatment A)
Number of subjects: 18
Study 22930487 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone 10-5-5 mg (treatment B)
Number of subjects: 18
Study 22930487 — intervention group
Group type: COMPARATOR
Intervention: Prednisone 5 mg (treatment C)
Number of subjects: 18
Study 19180569 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy supplements (82 mg/day aglycone equivalents)
Number of subjects: 19
Study 19180569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 17971234 — intervention group
Group type: EXPERIMENTAL
Intervention: Proctored ultrasound hands-on instruction
Number of subjects: 30
Study 17971234 — intervention group
Group type: COMPARATOR
Intervention: Control group with no hands-on instruction
Number of subjects: 30
Study 17971234 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty group
Number of subjects: 30
Study 17971234 — intervention group
Group type: EXPERIMENTAL
Intervention: Proctored ultrasound examinations
Number of subjects: 30
Study 15144425 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS) treatment
Number of subjects: 0
Study 15144425 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 11148443 — intervention group
Group type: EXPERIMENTAL
Intervention: High calorie meal (842 kcal)
Number of subjects: 12
Study 11148443 — intervention group
Group type: COMPARATOR
Intervention: Low calorie meal (582 kcal)
Number of subjects: 12
Study 9648991 — intervention group
Group type: EXPERIMENTAL
Intervention: p-ANCA positivity in patients without pouchitis (50%)
Number of subjects: 49
Study 9648991 — intervention group
Group type: EXPERIMENTAL
Intervention: p-ANCA positivity in patients with pouchitis (68%)
Number of subjects: 49
Study 9648991 — intervention group
Group type: EXPERIMENTAL
Intervention: p-ANCA positivity in ulcerative colitis patients (46.9%)
Number of subjects: 49
Study 9648991 — intervention group
Group type: COMPARATOR
Intervention: p-ANCA positivity in healthy controls (0%)
Number of subjects: 49
Study 8025492 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized response technique (RR-technique)
Number of subjects: 2330
Study 8025492 — intervention group
Group type: COMPARATOR
Intervention: Direct response to sensitive questions
Number of subjects: 2330
Study 2809097 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosynthetic natural sequence hGH (somatropin)
Number of subjects: 200
Study 2809097 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.10 mg/kg thrice weekly
Number of subjects: 200
Study 2809097 — intervention group
Group type: COMPARATOR
Intervention: 0.06 mg/kg thrice weekly
Number of subjects: 200
Study 793005 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline tablets
Number of subjects: 0
Study 793005 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine with nortriptyline (f/n) tablets
Number of subjects: 0
Study 793005 — intervention group
Group type: COMPARATOR
Intervention: Control group (Amitriptyline)
Number of subjects: 0
Study 31932368 — intervention group
Group type: EXPERIMENTAL
Intervention: MMV390048 (20 mg)
Number of subjects: 100
Study 31932368 — intervention group
Group type: EXPERIMENTAL
Intervention: MMV390048 (up to 120 mg)
Number of subjects: 100
Study 31932368 — intervention group
Group type: EXPERIMENTAL
Intervention: MMV390048 (tablet formulations)
Number of subjects: 100
Study 31932368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 31218346 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-arm trials
Number of subjects: 0
Study 31218346 — intervention group
Group type: COMPARATOR
Intervention: Randomized comparative trials
Number of subjects: 0
Study 31218346 — intervention group
Group type: COMPARATOR
Intervention: Progression-free survival as a primary or coprimary outcome
Number of subjects: 0
Study 28278167 — intervention group
Group type: EXPERIMENTAL
Intervention: IC ECG guidance (n = 500)
Number of subjects: 1007
Study 28278167 — intervention group
Group type: COMPARATOR
Intervention: Anatomical landmark guidance (n = 507)
Number of subjects: 1007
Study 25935863 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide treatment (23 patients)
Number of subjects: 30
Study 25935863 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients (7 patients)
Number of subjects: 30
Study 24048550 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making intervention (digital video disc and booklet)
Number of subjects: 123
Study 24048550 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making intervention
Number of subjects: 123
Study 24048550 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 123
Study 21529211 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 hour with isoflurane
Number of subjects: 8
Study 21529211 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 hour with desflurane
Number of subjects: 8
Study 21529211 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 hours with isoflurane
Number of subjects: 8
Study 21529211 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 hours with desflurane
Number of subjects: 8
Study 19740396 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive plus rotigotine (2 mg on days 1-3, 3 mg maintenance thereafter)
Number of subjects: 40
Study 19740396 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo patches (instead of rotigotine)
Number of subjects: 40
Study 19740396 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive plus rotigotine
Number of subjects: 40
Study 17578934 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily positive mood states
Number of subjects: 0
Study 17578934 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood manipulations (Studies 2-5)
Number of subjects: 0
Study 17578934 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive mood states
Number of subjects: 0
Study 15390323 — intervention group
Group type: EXPERIMENTAL
Intervention: fenoldopam 0.1 microg/kg/minute
Number of subjects: 140
Study 15390323 — intervention group
Group type: COMPARATOR
Intervention: dopamine 3 microg/kg/minute
Number of subjects: 140
Study 15390323 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 140
Study 11606878 — intervention group
Group type: EXPERIMENTAL
Intervention: One of the QI interventions
Number of subjects: 1136
Study 11606878 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1136
Study 9672274 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg per day orally
Number of subjects: 2494
Study 9672274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2494
Study 8065798 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 16
Study 8065798 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 16
Study 3338232 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.15 mg/kg
Number of subjects: 11
Study 3338232 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.30 mg/kg
Number of subjects: 11
Study 3338232 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.50 mg/kg
Number of subjects: 11
Study 3338232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 29637529 — intervention group
Group type: EXPERIMENTAL
Intervention: ND0701
Number of subjects: 34
Study 29637529 — intervention group
Group type: COMPARATOR
Intervention: APO-go®
Number of subjects: 34
Study 27701366 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 116
Study 27701366 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 116
Study 23514730 — intervention group
Group type: EXPERIMENTAL
Intervention: sE-selectin
Number of subjects: 1237
Study 23514730 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6
Number of subjects: 1237
Study 23514730 — intervention group
Group type: EXPERIMENTAL
Intervention: PAI-1 (total and active)
Number of subjects: 1237
Study 23514730 — intervention group
Group type: EXPERIMENTAL
Intervention: TNFR-1 and TNFR-2
Number of subjects: 1237
Study 20094015 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-mg estradiol and 0.5-mg norethisterone (hormone therapy)
Number of subjects: 55
Study 20094015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 19035712 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective surgical exploration
Number of subjects: 9
Study 19035712 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent decompression of the clot
Number of subjects: 9
Study 15974555 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-administered 6-month telephonic case management intervention (Asthma Treatment Awareness Project)
Number of subjects: 0